Syndax Pharmaceuticals (SNDX) Insider Trading & Ownership $20.93 +0.85 (+4.23%) (As of 07/5/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Syndax Pharmaceuticals (NASDAQ:SNDX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25,037.50Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$3.74 M SNDX Insider Buying and Selling by Quarter Ad Stansberry ResearchObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In fact, according to Tucker Carlson, in private even "Obama is telling people Biden can't win, and he is therefore in favor of an open convention."WHO will they replace Biden with? Syndax Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2024Keith A GoldanCFOBuy1,250$20.03$25,037.50 8/9/2023Briggs MorrisonDirectorSell52,855$18.27$965,660.85 8/2/2023William MeuryDirectorSell83,000$20.46$1,698,180.00 7/10/2023Briggs MorrisonDirectorSell52,855$20.40$1,078,242.00 (Data available from 1/1/2013 forward) SNDX Insider Trading Activity - Frequently Asked Questions Who is on Syndax Pharmaceuticals's Insider Roster? The list of insiders at Syndax Pharmaceuticals includes Alexander Nolte, Briggs Morrison, Dennis Podlesak, Fabrice Egros, Keith A Goldan, Keith Katkin, Michael A Metzger, Peter Ordentlich, Pierre Legault, and William Meury. Learn more on insiders at SNDX. What percentage of Syndax Pharmaceuticals stock is owned by insiders? 4.10% of Syndax Pharmaceuticals stock is owned by insiders. Learn more on SNDX's insider holdings. Which Syndax Pharmaceuticals insiders have been buying company stock? The following insider purchased SNDX shares in the last 24 months: Keith A Goldan ($25,037.50). How much insider buying is happening at Syndax Pharmaceuticals? Insiders have purchased a total of 1,250 SNDX shares in the last 24 months for a total of $25,037.50 bought. Which Syndax Pharmaceuticals insiders have been selling company stock? The following insiders have sold SNDX shares in the last 24 months: Briggs Morrison ($10,938,923.14), Dennis Podlesak ($280,574.25), Keith A Goldan ($12,872.87), Keith Katkin ($868,158.37), Michael A Metzger ($2,015,594.59), Peter Ordentlich ($1,467,078.00), Pierre Legault ($641,760.00), and William Meury ($1,698,180.00). How much insider selling is happening at Syndax Pharmaceuticals? Insiders have sold a total of 792,177 Syndax Pharmaceuticals shares in the last 24 months for a total of $17,923,141.22 sold. More Insider Trading Tools from MarketBeat Related Companies: PTGX Insider Selling AMPH Insider Selling ENTA Insider Selling BPMC Insider Selling MDGL Insider Selling SMMT Insider Selling CYTK Insider Selling OGN Insider Selling VKTX Insider Selling NUVL Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, TreaceIs CAVA Overextended? A Closer Look at This High-Flying StockOccidental Petroleum: Buffett Causes OXY Stock Rebound3 Tech Stocks Insiders, Major Shareholders, and Institutions BuyThe Top 3 Stocks Sold by Insiders This Quarter This page (NASDAQ:SNDX) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Syndax Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.